Former FDA Commissioner Scott Gottlieb

On the vaccine supply and distribution, the future of the ACA, and drug pricing legislation.

By Sandy Laycox Posted on February 2, 2021

Dr. Scott Gottlieb, former FDA commissioner and a current Pfizer board member, shares his thoughts on the COVID-19 vaccine distribution.

He also discusses supply successes and challenges, potential drug pricing legislation, and the future of the ACA. At the center of the conversation? The employer role.

Sandy Laycox Editor in Chief Read More

See More: COVID-19 Employee Benefits Medicare

More in Podcasts

Podcasts Primary Focus on Secondary Perils

Discussing 2026 risk trends with AXA XL's Michele Sansone.

Sponsored By AXA XL

Podcasts Introduction to Humanity with David Brooks

New York Times columnist and author David Brooks on life, learning, an...

Podcasts Personal Lines with Andy Barker

A conversation with the CEO of Houchens Insurance Group

Podcasts Politics and Risk Special Edition: Stories From White House Alumni Matt Kirk and Audra Jackson

A conversation with the current head of North American retail placement at Acris...

Podcasts Politics and Risk with Rep. Kevin Hern

A conversation around the future of ICHRAs and tort reform.

Podcasts Personal Lines with Joseph Schauer

A conversation with the President and CEO of Schauer Group

Having previously served as chief futurist at Deloitte, global innovation director at Accenture, a venture capital co-founder, and an inventor, Mike Bechtel has more than 25 years of experience with technology and innovation.

Podcasts What’s Now, What’s New, What’s Next in Tech